Of significant concern, Czech mortality rates from ischaemic heart diseases and stroke remain the fourth highest in the OECD at 260.4 and 106.4 deaths respectively per 100 000 population in 2011 (compared to OECD averages of 122.2 and 69.1). This chapter explores the quality of these services for breast, cervical and colorectal cancer - the three cancers with the highest mortality burden in the Czech Republic for which screening is available. The quality of primary and secondaiy prevention for cardiovascular diseases (including diabetes, the focus of chapter 4) is also considered.